CeriBell, Inc. (CBLL) vs SiBone (SIBN)
CeriBell, Inc. and SiBone are both Medical Devices companies. CeriBell, Inc. is the larger, with a market value of $914.2M against $830.0M — 1.1× the size. CeriBell, Inc. grew revenue faster over the last twelve months: 31.7% against 15.3%. SiBone has the higher net margin (−6.85% vs −64.7%) and the higher return on invested capital (−15.4% vs −229.8%). Across the 17 metrics below, SiBone leads on 11 and CeriBell, Inc. on 6.
Valuation
Profitability
| Metric | CBLL | SIBN | Medical Devices median |
|---|---|---|---|
| Gross margin | 88.90% | 79.53% | 56.01% |
| Operating margin | (68.62%) | (8.31%) | (15.03%) |
| Net margin | (64.73%) | (6.85%) | (20.40%) |
| Free cash flow margin | (55.02%) | (2.05%) | (7.24%) |
| Return on equity | (43.93%) | (8.30%) | (15.32%) |
| Return on assets | (35.29%) | (6.10%) | (19.72%) |
| Return on invested capital | (229.76%) | (15.40%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack